Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 7425 - 7432 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN5996 | Decanedioic acid |
|
Decanedioic acid is a saturated, straight-chain naturally occurring dicarboxylic acid, it exhibits significantly higher anti-HIV activity.
|
|
| BCN5998 | Nyasicoside |
|
1. Nyasicoside may have promising and beneficial thrombolytic activity.
|
|
| BCN5999 | Nyasicol |
|
1. Nyasicol is a precursor of interjectin.
|
|
| BCN6000 | Adenanthin |
|
1. Adenanthin has bacteriostatic activity.
2. Adenanthin has antiinflammatory activity. 3. Adenanthin has antitumour activity . 4. Adenanthin is a novel NF-κB and nucleophilic cysteines inhibitor. 5. Adenanthin has antileukemic activity through targeting peroxiredoxin I/II. 6. Adenanthin can serve as the development of Prx I– and Prx II–targeted therapeutic agents. |
|
| BCN6001 | Ikshusterol 3-O-glucoside |
|
Ikshusterol 3-O-glucoside has a potent snake-venom neutralizing capacity and it might be a potential molecule for the therapeutic treatment for snakebites.
|
|
| BCN6003 | Stigmastane-3,6-diol |
|
1. Stigmastane-3 beta, 6 alpha-diol and stigmastane-3 beta, 6 beta-diol possess marked inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced
inflammation in mice, the 50% inhibitory dose is 0.5--1.0 mg/ear. |
|
| BCN6004 | 2',5,7-Trihydroxy-8-methoxyflavanone |
|
1. 2',5,7-Trihydroxy-8-methoxyflavanone has cytotoxic activity.
|
|
| BCN6005 | Aristolactam FI |
|
1. Aristolactam FI shows platelet aggregation inhibitory activity.
2. Aristolactam FI are potential cancer chemotherapeutic and chemopreventive agents. |
|